Evidence map›Paper›PMID 36340803›Full record

Article3 Biotech2022

Identification of an anti-herpetic compound isolated from

Rihab Chhoud, Lamjed Bouslama, Dorra Gharbi, Fatma Nouira, Adele Papetti, Hatem Majdoub

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rihab ChhoudLaboratory of Interfaces and Advanced Materials (LR11ES55), Faculty of Sciences of Monastir, University of Monastir, Bd. of the Environment, 5019 Monastir, Tunisia.ORCID 0000-0002-8286-5678
Lamjed BouslamaLaboratory of Bioactive Substances - LR15CBBC03, Center of Biotechnology of Borj Cedria, University of Tunis El Manar, BP 901, 2050 Hammam Lif, Tunisia.
Dorra GharbiLaboratory of Bioactive Substances - LR15CBBC03, Center of Biotechnology of Borj Cedria, University of Tunis El Manar, BP 901, 2050 Hammam Lif, Tunisia.
Fatma NouiraLaboratory of Bioactive Substances - LR15CBBC03, Center of Biotechnology of Borj Cedria, University of Tunis El Manar, BP 901, 2050 Hammam Lif, Tunisia.
Adele PapettiNutraceutical and Food Chemical-Toxicological Analysis Laboratory, Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
Hatem MajdoubLaboratory of Interfaces and Advanced Materials (LR11ES55), Faculty of Sciences of Monastir, University of Monastir, Bd. of the Environment, 5019 Monastir, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the numerous side effects of conventional drugs against herpetic infections and the growing phenomenon of resistance, the researchers turned to natural compounds as a source of new drugs because they are less toxic than the synthetic molecules. This study aimed to analyse the activity of

Indexed as

Antiviral activityCytotoxicityGallic acidHerpes virusMale floral budsPistacia vera L.

Identifiers

PMID36340803
PMCPMC9626729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.